A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities

NCT ID: NCT01715818

Last Updated: 2016-11-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

1999 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-12-31

Study Completion Date

2013-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized, double-blind, placebo-controlled, parallel group, multicenter study will evaluate the potential of aleglitazar to reduce cardiovascular risk in patients with stable cardiovascular disease and glucose abnormalities. Patients will be randomized 1:1 to receive either aleglitazar 150 mcg orally daily or matching placebo.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Disease, Diabetes Mellitus Type 2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aleglitazar

Group Type EXPERIMENTAL

aleglitazar

Intervention Type DRUG

150 mcg orally daily

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

matching aleglitazar placebo tablet orally daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo

matching aleglitazar placebo tablet orally daily

Intervention Type DRUG

aleglitazar

150 mcg orally daily

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female patients with established evidence of stable cardiovascular disease (CVD) defined as at least one of the following groups of criteria (A or B) A. Age \>/= 40 years with history with prior CV event of prior myocardial infarction or prior ischemic stroke (confirmed by brain imaging study), with onset \>/= 3 months prior to randomization and stable in the Investigator's judgment B. Age \>/= 55 years with evidence of CVD (stable in the Investigator's judgment), defined as at least one of the following: Coronary disease, cerebrovascular disease or peripheral arterial disease as defined by protocol
* Patients with glucose abnormalities based on one of the following A-B criteria:

A. Established Type 2 diabetes mellitus (T2D) according to 2010 ADA criteria; treatment may include diet alone, or any glucose-lowering therapies except for thiazolidinediones (TDZs) B. No fulfillment of criterion A) but evidence of glucose abnormalities

* Optimal management of CV risk factors including hypertension and dyslipidemia as informed by the best evidence and clinical practice guidelines

Exclusion Criteria

* Current treatment with a thiazolidinedione (TDZ) or fibrate
* Prior intolerance to a TDZ or fibrate
* Previous participation in a trial with aleglitazar
* Other types of diabetes
* Inadequate liver, hematologic or renal function
* Symptomatic heart failure classified as NYHA class II-IV
* Hospitalization for a primary diagnosis of heart failure in the 12-month period preceding randomization
* Peripheral edema which in the judgment of the Investigator in believed to be severe and of cardiac origin
* History of surgical coronary revascularization (CABG) less than 5 years prior to screening, except in cases of subsequent myocardial infarction
* Currently scheduled for arterial revascularization procedures
* Systemic corticosteroid therapy for \> 2 weeks within 3 months prior to screening
* Diagnosed or treated malignancy (except for treated basal cell skin cancer, in situ carcinoma of the cervix, or in situ prostate cancer) within the past 5 years
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hoffmann-La Roche

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Trials

Role: STUDY_DIRECTOR

Hoffmann-La Roche

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mortimer, , United Kingdom

Site Status

Reading, , United Kingdom

Site Status

Soham, Ely, , United Kingdom

Site Status

Armadale, Western Australia, Australia

Site Status

Perth, Western Australia, Australia

Site Status

Braunau am Inn, , Austria

Site Status

Feldkirch, , Austria

Site Status

Graz, , Austria

Site Status

Vienna, , Austria

Site Status

Kelowna, British Columbia, Canada

Site Status

Surrey, British Columbia, Canada

Site Status

Winnipeg, Manitoba, Canada

Site Status

Bathurst, New Brunswick, Canada

Site Status

Cambridge, Ontario, Canada

Site Status

Collingwood, Ontario, Canada

Site Status

Greater Sudbury, Ontario, Canada

Site Status

Hamilton, Ontario, Canada

Site Status

London, Ontario, Canada

Site Status

London, Ontario, Canada

Site Status

Newmarket, Ontario, Canada

Site Status

Newmarket, Ontario, Canada

Site Status

Sarnia, Ontario, Canada

Site Status

Toronto, Ontario, Canada

Site Status

Toronto, Ontario, Canada

Site Status

Quebec, Prince Edward Island, Canada

Site Status

Chicoutimi, Quebec, Canada

Site Status

Chicoutimi, Quebec, Canada

Site Status

Granby, Quebec, Canada

Site Status

Lachine, Quebec, Canada

Site Status

Laval, Quebec, Canada

Site Status

Longueuil, Quebec, Canada

Site Status

Montreal, Quebec, Canada

Site Status

Montreal, Quebec, Canada

Site Status

Montreal, Quebec, Canada

Site Status

Montreal, Quebec, Canada

Site Status

Montreal, Quebec, Canada

Site Status

Québec, Quebec, Canada

Site Status

Saint-Charles-Borromée, Quebec, Canada

Site Status

Saint-Jérôme, Quebec, Canada

Site Status

Saint-Lambert, Quebec, Canada

Site Status

Sherbrooke, Quebec, Canada

Site Status

Ste-Foy, Quebec, Canada

Site Status

Terrebonne, Quebec, Canada

Site Status

Saskatoon, Saskatchewan, Canada

Site Status

Las Condes, , Chile

Site Status

Santiago, , Chile

Site Status

Santiago, , Chile

Site Status

Santiago, , Chile

Site Status

Temuco, , Chile

Site Status

Temuco, , Chile

Site Status

Temuco, , Chile

Site Status

Barranquila, , Colombia

Site Status

Barranquilla, , Colombia

Site Status

Bogotá, , Colombia

Site Status

Cartagena, , Colombia

Site Status

Floridablanca, , Colombia

Site Status

Medellín, , Colombia

Site Status

Beroun, , Czechia

Site Status

Brno, , Czechia

Site Status

Brno, , Czechia

Site Status

Jihlava, , Czechia

Site Status

Liberec, , Czechia

Site Status

Prague, , Czechia

Site Status

Prague, , Czechia

Site Status

Prague, , Czechia

Site Status

Prague, , Czechia

Site Status

Prague, , Czechia

Site Status

Prague, , Czechia

Site Status

Prague, , Czechia

Site Status

Prague, , Czechia

Site Status

Praha 4 - Krc, , Czechia

Site Status

Slaný, , Czechia

Site Status

Třebíč, , Czechia

Site Status

Narva, , Estonia

Site Status

Tallinn, , Estonia

Site Status

Tartu, , Estonia

Site Status

Tartu, , Estonia

Site Status

Berlin, , Germany

Site Status

Berlin, , Germany

Site Status

Bochum, , Germany

Site Status

Charlottenburg, , Germany

Site Status

Chemnitz, , Germany

Site Status

Cologne, , Germany

Site Status

Damme, , Germany

Site Status

Dresden, , Germany

Site Status

Frankfurt, , Germany

Site Status

Frankfurt, , Germany

Site Status

Hanover, , Germany

Site Status

Homburg/Saar, , Germany

Site Status

Kassel, , Germany

Site Status

Köthen, , Germany

Site Status

Leipzig, , Germany

Site Status

Magdeburg, , Germany

Site Status

Mönchengladbach, , Germany

Site Status

Münster, , Germany

Site Status

Neunkirchen, , Germany

Site Status

Wangen, , Germany

Site Status

Balatonfüred, , Hungary

Site Status

Budapest, , Hungary

Site Status

Budapest, , Hungary

Site Status

Budapest, , Hungary

Site Status

Budapest, , Hungary

Site Status

Budapest, , Hungary

Site Status

Budapest, , Hungary

Site Status

Budapest, , Hungary

Site Status

Debrecen, , Hungary

Site Status

Gyöngyös, , Hungary

Site Status

Mosonmagyaróvár, , Hungary

Site Status

Nyíregyháza, , Hungary

Site Status

Pápa, , Hungary

Site Status

Szeged, , Hungary

Site Status

Székesfehérvár, , Hungary

Site Status

Szolnok, , Hungary

Site Status

Zalaegerszeg, , Hungary

Site Status

Giv‘atayim, , Israel

Site Status

Naples, Campania, Italy

Site Status

Napoli, Campania, Italy

Site Status

Bologna, Emilia-Romagna, Italy

Site Status

Rome, Lazio, Italy

Site Status

Rome, Lazio, Italy

Site Status

Milan, Lombardy, Italy

Site Status

Milan, Lombardy, Italy

Site Status

Pavia, Lombardy, Italy

Site Status

Catania, Sicily, Italy

Site Status

Palermo, Sicily, Italy

Site Status

Pesaro, The Marches, Italy

Site Status

Massa, Tuscany, Italy

Site Status

Tochigi, , Japan

Site Status

Liepāja, , Latvia

Site Status

Riga, , Latvia

Site Status

Riga, , Latvia

Site Status

Riga, , Latvia

Site Status

Riga, , Latvia

Site Status

Kaunas, , Lithuania

Site Status

Kaunas, , Lithuania

Site Status

Kaunas, , Lithuania

Site Status

Vilnius, , Lithuania

Site Status

Johor Bahru, , Malaysia

Site Status

Kuala Lumpur, , Malaysia

Site Status

Kuala Selangor, , Malaysia

Site Status

Perak, , Malaysia

Site Status

Sabak Bernam, , Malaysia

Site Status

Sarawak, , Malaysia

Site Status

Aguascalientes, , Mexico

Site Status

México, , Mexico

Site Status

Monclova, , Mexico

Site Status

Monterrey, , Mexico

Site Status

Xalapa, , Mexico

Site Status

Bialystok, , Poland

Site Status

Gdynia, , Poland

Site Status

Gdynia, , Poland

Site Status

Katowice, , Poland

Site Status

Katowice, , Poland

Site Status

Krakow, , Poland

Site Status

Krakow, , Poland

Site Status

Krakow, , Poland

Site Status

Krakow, , Poland

Site Status

Lodz, , Poland

Site Status

Lublin, , Poland

Site Status

Lublin, , Poland

Site Status

Nowy Sącz, , Poland

Site Status

Opole, , Poland

Site Status

Rzeszów, , Poland

Site Status

Warsaw, , Poland

Site Status

Wroclaw, , Poland

Site Status

Baia Mare, , Romania

Site Status

Bucharest, , Romania

Site Status

Bucharest, , Romania

Site Status

Bucharest, , Romania

Site Status

Bucharest, , Romania

Site Status

Bucharest, , Romania

Site Status

Bucharest, , Romania

Site Status

Craiova, , Romania

Site Status

Oradea, , Romania

Site Status

Ploieşti, , Romania

Site Status

Târgu Mureş, , Romania

Site Status

Kemerovo, , Russia

Site Status

Saint Petersburg, , Russia

Site Status

Tomsk, , Russia

Site Status

Pretoria, , South Africa

Site Status

Pretoria West, , South Africa

Site Status

Busan, , South Korea

Site Status

Busan, , South Korea

Site Status

Daejeon, , South Korea

Site Status

Gwangju, , South Korea

Site Status

Gyeonggi-do, , South Korea

Site Status

Gyeonggi-do, , South Korea

Site Status

Gyeonggi-do, , South Korea

Site Status

Gyeonggi-do, , South Korea

Site Status

Gyeonggi-do, , South Korea

Site Status

Incheon, , South Korea

Site Status

Seoul, , South Korea

Site Status

Seoul, , South Korea

Site Status

Seoul, , South Korea

Site Status

Seoul, , South Korea

Site Status

Seoul, , South Korea

Site Status

Suwon, , South Korea

Site Status

Wŏnju, , South Korea

Site Status

Albacete, Albacete, Spain

Site Status

Sant Joan d'Alacant, Alicante, Spain

Site Status

Almería, Almeria, Spain

Site Status

Palma de Mallorca, Balearic Islands, Spain

Site Status

Barcelona, Barcelona, Spain

Site Status

Barcelona, Barcelona, Spain

Site Status

Barcelona, Barcelona, Spain

Site Status

Barcelona, Barcelona, Spain

Site Status

L'Hospitalet de Llobregat, Barcelona, Spain

Site Status

Girona, Girona, Spain

Site Status

Granada, Granada, Spain

Site Status

Huelva, Huelva, Spain

Site Status

Santiago de Compostela, La Coruña, Spain

Site Status

Lleida, Lerida, Spain

Site Status

Madrid, Madrid, Spain

Site Status

Málaga, Malaga, Spain

Site Status

Málaga, Malaga, Spain

Site Status

Málaga, Malaga, Spain

Site Status

Seville, Sevilla, Spain

Site Status

Tarragona, Tarragona, Spain

Site Status

Alzira, Valencia, Spain

Site Status

Valencia, Valencia, Spain

Site Status

Malmo, , Sweden

Site Status

Stockholm, , Sweden

Site Status

Stockholm, , Sweden

Site Status

Stockholm, , Sweden

Site Status

Bangkok, , Thailand

Site Status

Khon Kaen, , Thailand

Site Status

Birmingham, , United Kingdom

Site Status

Cardiff, , United Kingdom

Site Status

Chorley, , United Kingdom

Site Status

Edinburgh, , United Kingdom

Site Status

Glasgow, , United Kingdom

Site Status

Glasgow, , United Kingdom

Site Status

Inverness, , United Kingdom

Site Status

Liverpool, , United Kingdom

Site Status

Liverpool, , United Kingdom

Site Status

Manchester, , United Kingdom

Site Status

Muscle Shoals, Alabama, United States

Site Status

Gilbert, Arizona, United States

Site Status

Phoenix, Arizona, United States

Site Status

Tucson, Arizona, United States

Site Status

Cudahy, California, United States

Site Status

Encino, California, United States

Site Status

Fresno, California, United States

Site Status

Fresno, California, United States

Site Status

Hawaiian Gardens, California, United States

Site Status

Huntington Beach, California, United States

Site Status

Lomita, California, United States

Site Status

Long Beach, California, United States

Site Status

Los Angeles, California, United States

Site Status

Los Angeles, California, United States

Site Status

Los Angeles, California, United States

Site Status

Los Gatos, California, United States

Site Status

North Hollywood, California, United States

Site Status

Northridge, California, United States

Site Status

Roseville, California, United States

Site Status

Sacramento, California, United States

Site Status

San Diego, California, United States

Site Status

Stockton, California, United States

Site Status

Thousand Oaks, California, United States

Site Status

Torrance, California, United States

Site Status

Tustin, California, United States

Site Status

Ventura, California, United States

Site Status

Denver, Colorado, United States

Site Status

Atlantis, Florida, United States

Site Status

Bradenton, Florida, United States

Site Status

Brooksville, Florida, United States

Site Status

Clearwater, Florida, United States

Site Status

Clearwater, Florida, United States

Site Status

DeLand, Florida, United States

Site Status

Fort Lauderdale, Florida, United States

Site Status

Hialeah, Florida, United States

Site Status

Hialeah, Florida, United States

Site Status

Kissimmee, Florida, United States

Site Status

Miami, Florida, United States

Site Status

Miami, Florida, United States

Site Status

Miami Beach, Florida, United States

Site Status

New Port Richey, Florida, United States

Site Status

Orlando, Florida, United States

Site Status

Panama City, Florida, United States

Site Status

Pinellas Park, Florida, United States

Site Status

Port Charlotte, Florida, United States

Site Status

Sarasota, Florida, United States

Site Status

St. Petersburg, Florida, United States

Site Status

Tampa, Florida, United States

Site Status

West Palm Beach, Florida, United States

Site Status

Winter Park, Florida, United States

Site Status

Augusta, Georgia, United States

Site Status

Decatur, Georgia, United States

Site Status

Dunwoody, Georgia, United States

Site Status

Eagle, Idaho, United States

Site Status

Idaho Falls, Idaho, United States

Site Status

Melrose Park, Illinois, United States

Site Status

Brownsburg, Indiana, United States

Site Status

Evansville, Indiana, United States

Site Status

Valparaiso, Indiana, United States

Site Status

Council Bluffs, Iowa, United States

Site Status

Iowa City, Iowa, United States

Site Status

Wichita, Kansas, United States

Site Status

Lexington, Kentucky, United States

Site Status

Louisville, Kentucky, United States

Site Status

Owensboro, Kentucky, United States

Site Status

Alexandria, Louisiana, United States

Site Status

Bangor, Maine, United States

Site Status

Baltimore, Maryland, United States

Site Status

Baltimore, Maryland, United States

Site Status

Baltimore, Maryland, United States

Site Status

Oxon Hill, Maryland, United States

Site Status

Haverhill, Massachusetts, United States

Site Status

Traverse City, Michigan, United States

Site Status

Fall Rivers, Mississippi, United States

Site Status

Kansas City, Missouri, United States

Site Status

Bellevue, Nebraska, United States

Site Status

Fremont, Nebraska, United States

Site Status

Las Vegas, Nevada, United States

Site Status

Las Vegas, Nevada, United States

Site Status

Las Vegas, Nevada, United States

Site Status

Elizabeth, New Jersey, United States

Site Status

Albany, New York, United States

Site Status

North Massapequa, New York, United States

Site Status

Smithtown, New York, United States

Site Status

Syracuse, New York, United States

Site Status

Westfield, New York, United States

Site Status

Elizabeth City, North Carolina, United States

Site Status

Morganton, North Carolina, United States

Site Status

Raleigh, North Carolina, United States

Site Status

Shelby, North Carolina, United States

Site Status

Winston-Salem, North Carolina, United States

Site Status

Fargo, North Dakota, United States

Site Status

Akron, Ohio, United States

Site Status

Gallipolis, Ohio, United States

Site Status

Kettering, Ohio, United States

Site Status

Zanesville, Ohio, United States

Site Status

Oklahoma City, Oklahoma, United States

Site Status

Tulsa, Oklahoma, United States

Site Status

Portland, Oregon, United States

Site Status

Beaver, Pennsylvania, United States

Site Status

Doylestown, Pennsylvania, United States

Site Status

Fleetwood, Pennsylvania, United States

Site Status

Harleysville, Pennsylvania, United States

Site Status

Jersey Shore, Pennsylvania, United States

Site Status

Lansdale, Pennsylvania, United States

Site Status

Philadelphia, Pennsylvania, United States

Site Status

Pittsburgh, Pennsylvania, United States

Site Status

Sellersville, Pennsylvania, United States

Site Status

Uniontown, Pennsylvania, United States

Site Status

Clinton, South Carolina, United States

Site Status

Greer, South Carolina, United States

Site Status

Murrells Inlet, South Carolina, United States

Site Status

Varnville, South Carolina, United States

Site Status

Dakota Dunes, South Dakota, United States

Site Status

Chattanooga, Tennessee, United States

Site Status

Chattanooga, Tennessee, United States

Site Status

Jackson, Tennessee, United States

Site Status

Knoxville, Tennessee, United States

Site Status

Nashville, Tennessee, United States

Site Status

Arlington, Texas, United States

Site Status

Corpus Christi, Texas, United States

Site Status

Dallas, Texas, United States

Site Status

El Paso, Texas, United States

Site Status

Houston, Texas, United States

Site Status

Houston, Texas, United States

Site Status

Houston, Texas, United States

Site Status

Kingwood, Texas, United States

Site Status

McAllen, Texas, United States

Site Status

New Braunfels, Texas, United States

Site Status

North Richland Hills, Texas, United States

Site Status

San Antonio, Texas, United States

Site Status

San Antonio, Texas, United States

Site Status

Tyler, Texas, United States

Site Status

Bountiful, Utah, United States

Site Status

Draper, Utah, United States

Site Status

Murray, Utah, United States

Site Status

Salt Lake City, Utah, United States

Site Status

Burke, Virginia, United States

Site Status

Manassas, Virginia, United States

Site Status

Suffolk, Virginia, United States

Site Status

Port Orchard, Washington, United States

Site Status

Spokane, Washington, United States

Site Status

Madison, Wisconsin, United States

Site Status

Caba, , Argentina

Site Status

Caba, , Argentina

Site Status

Camperdown, New South Wales, Australia

Site Status

Gosford, New South Wales, Australia

Site Status

Kogarah, New South Wales, Australia

Site Status

Wollongong, New South Wales, Australia

Site Status

South Brisbane, Queensland, Australia

Site Status

Adelaide, South Australia, Australia

Site Status

Woodville, South Australia, Australia

Site Status

Launceston, Tasmania, Australia

Site Status

Geelong, Victoria, Australia

Site Status

Heidelberg, Victoria, Australia

Site Status

Melbourne, Victoria, Australia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil China Finland France India Indonesia Peru Philippines Ukraine United States Argentina Australia Austria Canada Chile Colombia Czechia Estonia Germany Hungary Israel Italy Japan Latvia Lithuania Malaysia Mexico Poland Romania Russia South Africa South Korea Spain Sweden Thailand United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2012-000671-16

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

BC28027

Identifier Type: -

Identifier Source: org_study_id